Archive

Post Archive: Alex Spira MD PhD FACP

Investigational Inhibitor of Active RAS Shows Clinical Promise - Alexander I. Spira, MD, PhD, FACP

Clinical Trials Search, Alex Spira MD PhD FACP, Clinical Trials and Research
October 16, 2023
Read More

Landmark Non-Small Cell Lung Cancer Study - Clinically Meaningful Improvement and Progression Free Survival, Alexander I. Spira, MD, PhD, FACP 

Lung Cancer Team, The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Lung Cancer, Non-Small Cell Lung Cancer
September 28, 2023
Read More

A Rare Breakthrough in the Treatment of Colorectal Cancer Patients Harboring a KRAS mutation.

Alex Spira MD PhD FACP, Colon & Rectal Cancer, Clinical Trials and Research
March 7, 2023
Read More

NEXT-Virginia Opens Phase I Clinical Research Clinic for Oncology Patients in collaboration with Virginia Cancer Specialists

NEXT Oncology, The Research Institute, Alex Spira MD PhD FACP, Clinical Trials and Research, Press Releases
January 10, 2023
Read More

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C - Co-Author Alexandar Spira, MD, PhD, FACP

Alex Spira MD PhD FACP, Colon & Rectal Cancer
January 9, 2023
Read More

Advancements in Lung Cancer Treatment Provide Hope for Virginia Cancer Specialists Patients - Alexander I. Spira, MD, PhD, FACP

Lung Cancer Team, Alex Spira MD PhD FACP, Lung Cancer
November 10, 2022
Read More
Read More

Ground breaking research leading to breakthroughs in cancer treatments - Timothy A. McCarthy, MD

ASCO, Lung Cancer Team, Alex Spira MD PhD FACP, Lung Cancer, Small Cell Lung Cancer, Timothy A. McCarthy MD
July 11, 2022
Read More

Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial

NEXT Oncology, The Research Institute, Alex Spira MD PhD FACP, Non-Small Cell Lung Cancer
June 27, 2022
Read More

Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting - Alexander I. Spira, MD, PhD, FACP

Fairfax Office, Alex Spira MD PhD FACP
June 3, 2022
Read More